In ovarian cancer, the polymorphisms PD-1 rs2227982 and PD-L1 rs4143815 have been associated with increased cancer susceptibility and poor prognosis, particularly when PD-1 and PD-L1 expression levels are reduced [22]. Here, CD274 is linked to cancer.